Literature DB >> 5666012

Researches on the topical activity of benzydamine.

R Lisciani, P S Barcellona, B Silvestrini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5666012     DOI: 10.1016/0014-2999(68)90069-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  8 in total

1.  Animal models for the study of atypical anti-inflammatory agents.

Authors:  B Silvestrini
Journal:  Agents Actions       Date:  1986-01

Review 2.  [The therapeutic management of radiogenic oral mucositis].

Authors:  W Dörr; I Dölling-Jochem; M Baumann; T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

3.  Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners.

Authors:  Desiderio Passali; Maria Felice Arezzo; Alessandra De Rose; Gianmarco De Simone; Gianluigi Forte; Michalina Jablko-Musial; Ralph Mösges
Journal:  BMC Prim Care       Date:  2022-06-17

4.  Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects.

Authors:  P K Moore; P Wallace; Z Gaffen; S L Hart; R C Babbedge
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Comparative effects of drugs on four paw oedema models in the rat.

Authors:  D K Gemmell; J Cottney; A J Lewis
Journal:  Agents Actions       Date:  1979-04

6.  Pharmacology of benzydamine.

Authors:  P A Quane; G G Graham; J B Ziegler
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

7.  Effect of benzydamine on exocytosis and respiratory burst in human neutrophils and mononuclear phagocytes.

Authors:  M Baggiolini; P Mauderli; U Näf; B Catanese
Journal:  Agents Actions       Date:  1985-07

Review 8.  Cancer therapy and oral mucositis. An appraisal of drug prophylaxis.

Authors:  C J Verdi
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.